Income Statement

BIO-TECHNE CORP

TECH
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Revenue
1,219.64 1,159.06 1,136.70 1,105.60 931.03 738.69 714.01 - 563.00 499.02 452.25 357.76 310.58 314.56 289.96
Cost of Revenue
429.36 389.34 366.89 349.10 298.18 255.50 240.52 210.85 188.46 162.36 144.97 106.35 79.47 78.76 65.03
Gross Profit
790.27 769.73 769.82 756.50 632.85 483.19 473.49 432.14 374.54 336.66 307.28 251.41 231.11 235.80 224.94
Operating Expenses
688.02 563.04 470.87 459.91 395.55 325.78 326.77 295.97 253.96 186.07 160.25 91.66 72.64 69.60 61.88
Research & Development
99.50 96.66 92.49 87.14 70.60 65.19 62.41 55.33 53.51 45.19 40.85 30.95 29.26 27.91 25.99
Selling, General & Administrative
588.52 466.38 378.38 372.77 324.95 260.58 264.36 240.64 200.44 140.88 119.40 60.72 43.38 41.68 35.90
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
102.26 206.69 298.94 296.59 237.30 157.42 146.72 136.18 120.58 150.59 147.02 159.75 158.47 166.21 163.06
Non-Operating Income
-3.79 -21.00 39.72 4.80 0.51 119.06 -34.70 -10.23 -8.62 -3.11 7.14 1.64 2.19 -4.01 1.93
Interest Income
3.89 - 4.53 - - - - - - - - - - - -
Interest Expense
- - 11.22 11.31 13.95 19.20 21.71 10.19 7.36 1.75 1.54 - - - -
Other Non-Op Income / Expense
0.94 -6.84 -1.10 15.31 -75.64 137.65 -13.57 -0.45 -1.57 -1.61 8.05 -1.04 -0.45 -3.40 -1.83
Income Before Tax
98.46 185.69 338.66 301.39 148.18 276.48 112.02 125.95 111.96 147.48 154.16 169.86 165.66 170.77 -
Income Tax Expense
25.06 17.58 53.40 29.34 7.77 47.18 15.94 -0.20 35.88 43.01 -1.70 58.92 53.10 58.43 52.68
Non-Controlling Interest
- - 0.18 -8.95 -0.83 - - - - - - - - - -
Net Income
73.40 168.11 285.26 272.05 140.41 229.30 -96.07 -126.15 -76.09 104.48 -109.44 110.95 112.56 112.33 112.30
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
212.16 318.40 406.18 397.66 325.04 240.16 224.89 200.64 180.62 193.36 184.25 178.93 170.79 178.68 171.76
Earnings Per Share (Basic)
0.47 1.07 1.81 6.93 3.62 6.00 2.54 3.36 2.04 2.81 2.90 3.01 3.06 3.04 3.03
Diluted EPS
0.46 1.05 1.76 6.63 3.47 5.82 2.47 3.31 2.03 2.80 2.89 3.00 3.05 3.04 3.02
Weighted Average Shares
157.52 157.71 157.18 39.22 38.75 38.20 37.78 37.48 37.31 37.19 37.10 36.89 36.84 36.94 37.10
Diluted Weighted Avg Shares
159.72 160.77 161.86 41.03 40.48 39.40 38.89 38.06 37.50 37.33 37.23 37.01 36.90 37.01 37.17
Comprehensive Income
91.84 155.85 294.40 254.14 180.32 215.62 82.05 130.27 97.56 64.66 82.53 91.01 105.34 150.40 117.25